06.05.2022 • NewsHuntsmanPraxair

US Court Awards Huntsman Damages Against Praxair

A US court has awarded Huntsman damages in a long-running legal battle against Praxair, now part of Linde. A New Orleans jury has granted the Texas-headquartered chemical manufacturer nearly $94 million, which will exceed $125 million once the Court has applied interest.

Huntsman had accused Praxair of failing to properly maintain its own facility in Geismar, Louisiana, and then repeatedly failing to supply the contracted industrial gas volumes that the chemical company needed to manufacture polyurethane precursor MDI. The long-term supply contracts expired in 2013.

First filed in 2014, the case did not go to trial until this April, because of Covid-19 and other undisclosed factors. The 12-person jury unanimously agreed that Praxair had repeatedly breached its promises to Huntsman, directly causing substantial financial damages.

Peter Huntsman, chairman, president and CEO of Huntsman, said justice was “a very long time coming.” He praised, among others, the company’s polyurethane division and purchasing personnel who he said had “managed the constant operational and commercial upsets occurring when Praxair's poorly-maintained facilities went down from 2004 through 2013.”

In October 2018, Praxair merged with German rival Linde AG into a new company based in the UK and trading as Linde plc.

Author: Elaine Burridge, Freelance Journalist

Photo by Tingey Injury Law Firm on Unsplash
Photo by Tingey Injury Law Firm on Unsplash

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.